# Safety and Efficacy Study of Absnow Absorbable ASD Closure System For Treating ASD Patients

> **NCT03601039** · NA · COMPLETED · sponsor: **Lifetech Scientific (Shenzhen) Co., Ltd.** · enrollment: 165 (actual)

## Conditions studied

- Heart Septal Defects, Atrial
- Atrial Septal Defect

## Interventions

- **DEVICE:** Absnow Absorbable ASD Closure System

## Key facts

- **NCT ID:** NCT03601039
- **Lead sponsor:** Lifetech Scientific (Shenzhen) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-25
- **Primary completion:** 2020-08-28
- **Final completion:** 2024-08-30
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03601039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03601039, "Safety and Efficacy Study of Absnow Absorbable ASD Closure System For Treating ASD Patients". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT03601039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*